Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery

NCT00258297 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Withdrawn for lack of funding and accrual

Conditions

Esophageal Cancer

Interventions

DRUG: gefitinib
PROCEDURE: conventional surgery
PROCEDURE: enzyme inhibitor therapy
PROCEDURE: neoadjuvant therapy
PROCEDURE: protein tyrosine kinase inhibitor therapy
PROCEDURE: surgery

Sponsor

University of Rochester